175 related articles for article (PubMed ID: 17068344)
1. Ligand specificity of the anaphylatoxin C5L2 receptor and its regulation on myeloid and epithelial cell lines.
Johswich K; Martin M; Thalmann J; Rheinheimer C; Monk PN; Klos A
J Biol Chem; 2006 Dec; 281(51):39088-95. PubMed ID: 17068344
[TBL] [Abstract][Full Text] [Related]
2. The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74).
Cain SA; Monk PN
J Biol Chem; 2002 Mar; 277(9):7165-9. PubMed ID: 11773063
[TBL] [Abstract][Full Text] [Related]
3. The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein.
Kalant D; Cain SA; Maslowska M; Sniderman AD; Cianflone K; Monk PN
J Biol Chem; 2003 Mar; 278(13):11123-9. PubMed ID: 12540846
[TBL] [Abstract][Full Text] [Related]
4. Expression of receptors for anaphylatoxins C3a and C5a on rat islet preparations.
Tokodai K; Goto M; Inagaki A; Imura T; Nakanishi W; Satomi S
Transplant Proc; 2011 Nov; 43(9):3179-80. PubMed ID: 22099750
[TBL] [Abstract][Full Text] [Related]
5. C5L2, a nonsignaling C5A binding protein.
Okinaga S; Slattery D; Humbles A; Zsengeller Z; Morteau O; Kinrade MB; Brodbeck RM; Krause JE; Choe HR; Gerard NP; Gerard C
Biochemistry; 2003 Aug; 42(31):9406-15. PubMed ID: 12899627
[TBL] [Abstract][Full Text] [Related]
6. The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding.
Scola AM; Higginbottom A; Partridge LJ; Reid RC; Woodruff T; Taylor SM; Fairlie DP; Monk PN
J Biol Chem; 2007 Feb; 282(6):3664-71. PubMed ID: 17158873
[TBL] [Abstract][Full Text] [Related]
7. C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a.
Chen NJ; Mirtsos C; Suh D; Lu YC; Lin WJ; McKerlie C; Lee T; Baribault H; Tian H; Yeh WC
Nature; 2007 Mar; 446(7132):203-7. PubMed ID: 17322907
[TBL] [Abstract][Full Text] [Related]
8. An anti-inflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2.
Gerard NP; Lu B; Liu P; Craig S; Fujiwara Y; Okinaga S; Gerard C
J Biol Chem; 2005 Dec; 280(48):39677-80. PubMed ID: 16204243
[TBL] [Abstract][Full Text] [Related]
9. C5L2 is a functional receptor for acylation-stimulating protein.
Kalant D; MacLaren R; Cui W; Samanta R; Monk PN; Laporte SA; Cianflone K
J Biol Chem; 2005 Jun; 280(25):23936-44. PubMed ID: 15833747
[TBL] [Abstract][Full Text] [Related]
10. C5a- and ASP-mediated C5L2 activation, endocytosis and recycling are lost in S323I-C5L2 mutation.
Cui W; Simaan M; Laporte S; Lodge R; Cianflone K
Mol Immunol; 2009 Sep; 46(15):3086-98. PubMed ID: 19615750
[TBL] [Abstract][Full Text] [Related]
11. Human C3a and C3a desArg anaphylatoxins have conserved structures, in contrast to C5a and C5a desArg.
Bajic G; Yatime L; Klos A; Andersen GR
Protein Sci; 2013 Feb; 22(2):204-12. PubMed ID: 23184394
[TBL] [Abstract][Full Text] [Related]
12. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
[TBL] [Abstract][Full Text] [Related]
13. C5L2 and C5aR interaction in adipocytes and macrophages: insights into adipoimmunology.
Poursharifi P; Lapointe M; Pétrin D; Devost D; Gauvreau D; Hébert TE; Cianflone K
Cell Signal; 2013 Apr; 25(4):910-8. PubMed ID: 23268185
[TBL] [Abstract][Full Text] [Related]
14. C5a, but not C5a-des Arg, induces upregulation of heteromer formation between complement C5a receptors C5aR and C5L2.
Croker DE; Halai R; Fairlie DP; Cooper MA
Immunol Cell Biol; 2013; 91(10):625-33. PubMed ID: 24060963
[TBL] [Abstract][Full Text] [Related]
15. Recombinant C3adesArg/acylation stimulating protein (ASP) is highly bioactive: a critical evaluation of C5L2 binding and 3T3-L1 adipocyte activation.
Cui W; Lapointe M; Gauvreau D; Kalant D; Cianflone K
Mol Immunol; 2009 Oct; 46(16):3207-17. PubMed ID: 19767107
[TBL] [Abstract][Full Text] [Related]
16. C5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2: position 69 is the locus that determines agonism or antagonism.
Otto M; Hawlisch H; Monk PN; Müller M; Klos A; Karp CL; Köhl J
J Biol Chem; 2004 Jan; 279(1):142-51. PubMed ID: 14570896
[TBL] [Abstract][Full Text] [Related]
17. Complement C5a receptors in the pituitary gland: expression and function.
Francis K; Lewis BM; Monk PN; Ham J
J Endocrinol; 2008 Dec; 199(3):417-24. PubMed ID: 19020281
[TBL] [Abstract][Full Text] [Related]
18. C5a-stimulated recruitment of beta-arrestin2 to the nonsignaling 7-transmembrane decoy receptor C5L2.
Van Lith LH; Oosterom J; Van Elsas A; Zaman GJ
J Biomol Screen; 2009 Oct; 14(9):1067-75. PubMed ID: 19641221
[TBL] [Abstract][Full Text] [Related]
19. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a.
Gutzmer R; Köther B; Zwirner J; Dijkstra D; Purwar R; Wittmann M; Werfel T
J Invest Dermatol; 2006 Nov; 126(11):2422-9. PubMed ID: 16778800
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of the C3a and C5a receptors (CD88) by IFN-gamma and PMA in U937 cells and related myeloblastic cell lines.
Burg M; Martin U; Bock D; Rheinheimer C; Köhl J; Bautsch W; Klos A
J Immunol; 1996 Dec; 157(12):5574-81. PubMed ID: 8955209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
